Virus-neutralizing Antibodies to Hepatitis B Virus: The Nature of an Immunogenic Epitope on the S Gene Peptide

References

1. Cabral G. A., Marciano-Cabral F., Funk G. A., Sanchez Y., Hollinger F. B., Melnick J. L., Dreesman G.R. 1978; Cellular and humoral immunity in guinea pigs to two major polypeptides derived from hepatitis B surface antigen. Journal of General Virology 38:339–350
   [Google Scholar]
2. Dreesman G. R., Hollinger F. B., Melnick J. L. 1975; Biophysical and biochemical properties of purified preparations of hepatitis B surface antigen (HBsAg). American Journal of Medical Science 270:123–129
   [Google Scholar]
3. Goodall A. H., Miescher G., Meek F. L., Janossy G., Thomas H.C. 1981; Monoclonal antibodies in a solid-phase radiometric assay for HBsAg. Medical Laboratory Sciences 38:349–354
   [Google Scholar]
4. Hansson B. G., Purcell R. H. 1979; Sites that bind polymerised albumin on hepatitis B surface antigen particles: detection by radioimmunoassay. Infection and Immunity 26:125–130
   [Google Scholar]
5. Imai M., Yanase Y., Nojiri T., Niyakawa Y., Mayumi M. 1979; A receptor for polymerised human and chimpanzee albumins on hepatitis B virus particles co-occurring with HBeAg. Gastroenterology 76:242–247
   [Google Scholar]
6. Ionescu-Matiu I., Sandez Y., Hollinger F. B. 1980; Presence of a receptor for albumin on individual HBsAg polypeptides and on HBsAg produced by a hepatoma cell line. Journal of Medical Virology 6:175–178
   [Google Scholar]
7. Iwarson S., Tabor E., Thomas H. C., Goodall A., Waters J., Snoy P., Wai-Kuo Shih J., Gerety R. J. 1985; Neutralisation of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee. Journal of Medical Virology 16:89–95
   [Google Scholar]
8. Jilg W., Schmidt M., Zoulek G., Larbeer B., Wilske B., Deinhardt F. 1984; Clinical evaluation of a recombinant hepatitis B vaccine. Lancet ii:1174–1175
   [Google Scholar]
9. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
   [Google Scholar]
10. Lenkei R., Onica D., Ghetie B. 1977; Receptors for polymerised albumin on liver cells. Experientia 33:1046–1047
    [Google Scholar]
11. Machida A., Kishimoto S., Ohnuma H., Miyamoto H., Baba K., Oda K., Nakamuna T., Miyakawa Y., Mayumi M. 1983; A hepatitis B surface antigen polypeptide (p31) with the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology 85:268–274
    [Google Scholar]
12. Melnick J. L. 1981; Historical aspects of hepatitis B vaccine. In Hepatitis B Vaccine pp 23–31 Edited by Maupas P., Guesry P. Amsterdam: Elsevier/North-Holland;
    [Google Scholar]
13. Mishuiro S., Imai M., Takahashi K., Machido A., Gotanda T., Miyakawa Y., Mayumi M. 1980; A 49000 dalton polypeptide bearing all antigenic determinants and full immunogenicity of 22 nm hepatitis B surface antigen particles. Journal of Immunology 124:1589–1593
    [Google Scholar]
14. Neurath A. R., Kent S. B. H., Strick N. 1984; Location and chemical synthesis of a pre-S gene coded immunodominant epitope of hepatitis B virus. Science 224:392–395
    [Google Scholar]
15. Peterson D. L. 1981; Isolation and characterisation of the major protein and glycoprotein of hepatitis B surface antigen. Journal of Biological Chemistry 256:6975–6983
    [Google Scholar]
16. Renast I., Reiser J., Stark G. R. 1979; Transfer of proteins from gels to diazobenzyloxymethyl paper and detection with antisera: a method for studying antibody specificity and antigen structure. Proceedings of the National Academy of Sciences, U.S.A. 76:3116–3120
    [Google Scholar]
17. Skelly J., Howard C. R., Zuckerman A. J. 1981; Hepatitis B polypeptide vaccine preparation in micelle form. Nature, London 290:51–54
    [Google Scholar]
18. Stibbe W., Gerlich W. H. 1982; Variable protein composition of hepatitis B surface antigen from different donors. Virology 123:436–442
    [Google Scholar]
19. Szmuness W., Stevens C. D., Harley E. J., Zang E. A., Oleszko W. R., William D. C., Sadovsky R., Morrison J. M., Kellner A. 1980; Hepatitis B vaccine. Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. New England Journal of Medicine 303:833–841
    [Google Scholar]
20. Szmuness W., Stevens C. E., Harley E. J. 1982; Hepatitis B vaccine in medical staff of haemodialysis units: efficacy and subtype cross-protection. New England Journal of Medicine 307:1481–1486
    [Google Scholar]
21. Trevisan A., Gudat F., Guggenheim R., Krey G., Durmuller V., Luond G., Duggelin M., Landmann I., Tondelu P., Bianchi L. 1982; Demonstration of albumin receptors on isolated human hepatocytes by light and scanning electron microscopy. Hepatology 2:832
    [Google Scholar]
22. Zuckerman A. J., Howard C. R. 1979 Hepatitis Viruses of Man London: Academic Press;
    [Google Scholar]